(VIANEWS) – Shares of 10x Genomics (TXG) fell 7.21% to $171.50 at 10:31 EST on Thursday, following the last session’s upward trend. NASDAQ Composite is rising 0.34% to $14,830.70, after three sequential sessions in a row of gains. This seems, as yet, a somewhat bullish trend trading session today.
10x Genomics’s last close was $178.55, 14.57% under its 52-week high of $208.99.
Today’s last reported volume for 10x Genomics is 303951 which is 63.55% below its average volume of 833982.
The company’s growth estimates for the present quarter and the next is 36.6% and 69.2%, respectively.
10x Genomics’s Revenue
Year-on-year quarterly revenue growth grew by 47.2%, now sitting on 332.76M for the twelve trailing months.
10x Genomics’s last week, last month’s, and last quarter’s current volatility was a positive 0.16%, a negative 0.38%, and a positive 2.69%, respectively.
10x Genomics’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.91% (last week), 2.17% (last month), and 2.69% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
10x Genomics’s stock is considered to be overbought (>=80).
10x Genomics’s Stock Yearly Top and Bottom Value
10x Genomics’s stock is valued at $171.50 at 10:31 EST, way under its 52-week high of $208.99 and way above its 52-week low of $92.54.
10x Genomics’s Moving Average
10x Genomics’s value is below its 50-day moving average of $187.68 and below its 200-day moving average of $178.97.
More news about 10x Genomics (TXG).